Clinical Trial Update: A Trial of Neoadjuvant Therapy in Patients With Newly Diagnosed Glioblastoma [Phase 2]

View source ↗

Summary

A Phase 2 neoadjuvant therapy trial for newly diagnosed glioblastoma has been terminated.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Glioblastoma

Snippet

Sponsor: University College, London | Conditions: Glioblastoma | Phase 2 | Status: TERMINATED